AustinPx has introduced KinetiLease, a leasing program designed to provide pharmaceutical companies direct access to its KinetiSol research-scale equipment. The initiative enables companies to integrate this amorphous dispersion manufacturing tool into their own R&D labs, supporting drug development efforts for poorly
“We estimate about 8,000 metric tonnes of solvent per year are used by the industry to support solvent-based spray drying. That’s a significant impact on cost, maintenance, safety and the environment,” says Elizabeth Hickman, CEO of AustinPx, highlighting a critical
AustinPx, a contract development and manufacturing organisation (CDMO) specialising in bioavailability enhancement of orally delivered small molecule drug candidates, has announced its acquisition of a 3P Innovations API in capsule filling machine, a FT4 Powder Rheometer®, and the STYL’One Nano
AustinPx, a CDMO specialising in bioavailability enhancement of orally delivered small molecule drug candidates, and Microsize, a leading active pharmaceutical ingredient enhancement CDMO, announced a strategic partnership on January 31, 2024. The partnership aims to accelerate the commercial application of AustinPx’s
AustinPx, a contract development and manufacturing organisation (CDMO) specialising in analytical and formulation development services and cGMP manufacturing for small molecule drugs. The company announced the expansion of its capabilities to meet industry demand for the company’s services and expertise. It
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
